SectorPharmaceutical
Established Date25/03/2019
Listing Date02/02/2024
ExchangeNew York Stock Exchange
Full-time Employees68
Fiscal Year Ends31/12
Security TypeCommon stock
Office address650 Castro Street, Suite 450 Mountain View, CA 94041
Business
IntroductionAlto Neuroscience, Inc., was incorporated in Delaware on March 25, 2019. The company is a clinical-stage biopharmaceutical company focused on developing personalized treatment options for mental illness by leveraging its precision psychiatry platform to identify brain biomarkers. Its R&D pipeline includes clinical-stage assets for major depression, bipolar depression, schizophrenia and Parkinson's disease.
